Psilocybin (Usona Institute)
Sponsors
University of Washington, Oregon Health and Science University, Johns Hopkins University, James J. Peters Veterans Affairs Medical Center, Trent Emerick
Conditions
AgingAnhedoniaBiomarkers of AgingBurnout, CaregiverBurnout, ProfessionalCOVID-19Chronic Pelvic PainChronic Stroke
Early Phase 1
Phase 1
Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study
Not yet recruitingNCT06988319
Start: 2026-10-01End: 2027-12-31Target: 15Updated: 2026-08-03
Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability
RecruitingNCT07053917
Start: 2026-02-09End: 2027-03-01Target: 20Updated: 2026-02-13
Psilocybin to Treat Depression in Spinal Cord Injury
RecruitingNCT07251491
Start: 2026-08-06End: 2028-03-01Target: 30Updated: 2026-08-10
Psilocybin After Trauma Surgery for Pain
Not yet recruitingNCT07406828
Start: 2027-12-31End: 2029-08-01Target: 70Updated: 2026-08-06
Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects
RecruitingNCT07490353
Start: 2025-11-01End: 2028-05-31Target: 85Updated: 2026-03-24
Safety and Tolerability Trial of Psilocybin in Healthy Older Adults
RecruitingNCT07516405
Start: 2026-04-01End: 2028-03-01Target: 40Updated: 2026-08-10
Psilocybin Effects on Healthy Aging Biomarkers and Purpose in Life
Not yet recruitingNCT07719088
Start: 2026-12-01End: 2028-12-01Target: 50Updated: 2026-08-17